Sorriso Pharmaceuticals
PrivateLast Round
Series A
Dec 22, 2021
Est. Valuation
$50M
Total Funding Raised
$31M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sorriso Pharmaceuticals operates in Healthcare & Life Sciences and is based in Sandy, Utah. Its latest recorded funding round was a Series A round in December 2021.
Sorriso Pharmaceuticals is a biopharmaceutical company developing oral disease-modifying antibodies for the treatment of inflammatory diseases such as Crohn's disease and ulcerative colitis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sorriso Pharmaceuticals Comparables
Compare Sorriso Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Caldera Therapeutics | 88% | |
| GAT Biosciences S.L. | 86% | |
| Mage Biologics Inc. | 84% |
For institutional investors. Book with your work email.
Sorriso Pharmaceuticals Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Sorriso Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| A. M. Pappas & Associates | Series A |
| New Enterprise Associates | Series A |
| Lundbeckfonden BioCapital | Series A |
| Arix Bioscience | Series A |
| Biovision Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 14, 2026
Monthly visitors increased 46% MoM, reaching 1.9K.
- Jul 25, 2026
Monthly visitors increased 34% MoM, reaching 1.8K.
For institutional investors. Book with your work email.
Sorriso Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sorriso Pharmaceuticals's valuation, stock price, and market status.
Is Sorriso Pharmaceuticals a public or private company?
Sorriso Pharmaceuticals is a private company.
What is the current stock price of Sorriso Pharmaceuticals?
Sorriso Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Sorriso Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sorriso Pharmaceuticals worth (valuation)?
Sorriso Pharmaceuticals's valuation is estimated at $50.0M based on funding round data.
Can I buy Sorriso Pharmaceuticals stock?
Sorriso Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sorriso Pharmaceuticals's last funding round?
Sorriso Pharmaceuticals's most recent funding round was Series A on December 22, 2021.
Who are the main investors in Sorriso Pharmaceuticals?
Key investors in Sorriso Pharmaceuticals include New Enterprise Associates, Arix Bioscience.
Will Sorriso Pharmaceuticals IPO soon?
No public IPO plans have been announced for Sorriso Pharmaceuticals.
How can I track Sorriso Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Sorriso Pharmaceuticals's shares on secondary markets.